Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist
-
29/04/2026, 11:31
-
ansa.it
0
Scopri altro
- 29/06/2026, 11:31
-
ansa.it
-
0
- 29/06/2026, 11:25
-
ansa.it
-
0
- 29/06/2026, 11:25
-
lastampa.it
-
0
- 29/06/2026, 11:19
-
ansa.it
-
0
- 29/06/2026, 11:19
-
ansa.it
-
0
- 29/06/2026, 10:21
-
ansa.it
-
0
- 29/06/2026, 10:15
-
repubblica.it
-
0
Nessun commento